Copertina

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Siming Wu, Lei Zhang, Chao Hao, Binhao Ma, Zhaohui Li, Shurong Fan, Qianbin Li, Gaoyun Hu, Zhuo Chen
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
di: Yi‐Fan Zhang, et al.
Pubblicazione: (2024)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
di: Jingting Zeng, et al.
Pubblicazione: (2025)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
di: Jiayi Shen, et al.
Pubblicazione: (2025)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
di: Nurul Alam Inayatsyah, et al.
Pubblicazione: (2024)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
di: Ozge Kuyrukcu Ozturk, et al.
Pubblicazione: (2026)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
di: Jiayi Shen, et al.
Pubblicazione: (2024)

Design, Synthesis and Biological Evaluation of Aminoalkylated Paeonol Chalcone Derivatives
di: Jia‐chen Xu, et al.
Pubblicazione: (2026)

Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives
di: Bing He, et al.
Pubblicazione: (2025)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
di: Kalyani R. Thombre, et al.
Pubblicazione: (2026)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
di: Vijaykumar D. Nimbarte, et al.
Pubblicazione: (2025)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
di: Ayşen Işık, et al.
Pubblicazione: (2024)

Herbacetin Inhibits Human Fructose 1,6‐Bisphosphatase Among a Panel of Chromone Derivatives and Pyrazoles, Demonstrating Positive Effects on Insulin‐Resistant HepG2 Cells
di: Sónia Rocha, et al.
Pubblicazione: (2024)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
di: Ankit Kumar Singh, et al.
Pubblicazione: (2025)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
di: Rui Pereira, et al.
Pubblicazione: (2026)

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
di: Yuan‐Liang Gao, et al.
Pubblicazione: (2024)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
di: Qingxin Liu, et al.
Pubblicazione: (2025)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
di: Rameshwar S. Cheke, et al.
Pubblicazione: (2025)

Design, Synthesis and Pro‐Inflammatory Activity of Palmitoylated Derivatives of Thioglycolic Acid as New Immunomodulators
di: Samia M. Mohamed, et al.
Pubblicazione: (2024)

Ferulic Acid Inhibits Partial Epithelial‐Mesenchymal Transition in Renal Tubular Epithelial Cells and Mitigates Renal Interstitial Fibrosis by Regulating the HIF‐1α/Twist Signaling Pathway
di: Lin Xu, et al.
Pubblicazione: (2025)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2026)

Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
di: Wen‐Shuang Hou, et al.
Pubblicazione: (2025)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
di: Gözde Sayar, et al.
Pubblicazione: (2026)

A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors
di: Deniz A. Anakök, et al.
Pubblicazione: (2025)

Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents
di: Ecem Kaya‐Sezginer, et al.
Pubblicazione: (2024)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
di: Vladislav Lobanov, et al.
Pubblicazione: (2025)

Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in Hela Cells
di: Yue Li, et al.
Pubblicazione: (2024)

Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2025)

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”
di: Thiago Gonçalves dos Santos Martins
Pubblicazione: (2024)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
di: Farman Ullah, et al.
Pubblicazione: (2025)

Semisynthetic p‐Coumaric Acid Derivatives as Lead Dual Inhibitors Against DPP‐IV and GSK‐3β for Antidiabetic Therapy
di: Heberth de Paula, et al.
Pubblicazione: (2024)

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin
di: Ruihan Zhao, et al.
Pubblicazione: (2024)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
di: Shiying Zhang, et al.
Pubblicazione: (2025)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
di: Huiping Li, et al.
Pubblicazione: (2024)

Novel Silver(I) and Gold(I) N‐Heterocyclic Carbene Complexes Induce ROS ‐Dependent Autophagic Cell Death in Human Hepatoma Cell Line HepG2
di: Rocchina Miglionico, et al.
Pubblicazione: (2026)

Design and Synthesis of Holu‐7, a Quinazolinone Derivative With an Active Stereo Geometry and Polar 2,4‐Dihydroxyphenyl Group, as a Selective Anticancer Agent
di: Kuo‐Chu Lai, et al.
Pubblicazione: (2025)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
di: Zhiqi Lin, et al.
Pubblicazione: (2026)

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
di: Timoteo Delgado‐Maldonado, et al.
Pubblicazione: (2025)

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents
di: Pınar Poyraz Yılmaz, et al.
Pubblicazione: (2025)

Design of Hybrid Bioactive Peptides Derived From Cecropin and Cathepsin for Therapeutic Application
di: Gabriele Santos Cepinho, et al.
Pubblicazione: (2025)

Correction to “Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in HeLa Cells”
Pubblicazione: (2025)